Get the Stockscreener App
82.62
1.81%
-2.07
Sol Gel Technologies Ltd stock is traded at $82.62, with a volume of 97,630.
It is down -1.81% in the last 24 hours and down -0.05% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
See More
Previous Close:
$84.69
Open:
$85.16
24h Volume:
97,630
Relative Volume:
2.26
Market Cap:
$269.36M
Revenue:
$18.47M
Net Income/Loss:
$-1.05M
P/E Ratio:
-235.18
EPS:
-0.3513
Net Cash Flow:
$-33.87M
1W Performance:
-1.87%
1M Performance:
-0.05%
6M Performance:
+12.68%
1Y Performance:
+438.57%
1-Day Range:
$81.05
$90.50
1-Week Range:
$70.81
$90.79
52-Week Range:
$15.03
$97.97
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
82.40 | 276.85M | 18.47M | -1.05M | -33.87M | -0.3513 |
VRTX
Vertex Pharmaceuticals Inc
|
515.94 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
807.13 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
991.78 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
213.72 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.77 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Sol-Gel Technologies (SLGL) Projected to Announce Quarterly Earnings on Friday - MarketBeat
ELDN Stock Price and Chart — NASDAQ:ELDN - TradingView
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Sol Gel Technologies Ltd (SLGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sol-Gel Technologies (SLGL) Edges Lower as Stock Tests Key Support ZoneBuy Signal Reports - dars.gov.et
Sol Gel Technologies Ltd (SLGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SLGL|Sol Gel Technologies Ltd|Price:79.230|Chg%:-0.600 - TradingKey
Sol Gel Technologies Ltd (SLGL) Cash Flow - TradingKey
Sol Gel Technologies Ltd (SLGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sol Gel Technologies Ltd (SLGL) Institutional Confidence - TradingKey
TradingKey - TradingKey
Sol-Gel Technologies (SLGL) Climbs 2.17% as Bulls Test Resistance Near $86RVOL Spike - dars.gov.et
Affinity Asset Advisors LLC Purchases Shares of 35,000 Sol-Gel Technologies Ltd. $SLGL - MarketBeat
Sol-Gel Technologies Ltd. Revenue Breakdown – FWB:4SG - TradingView
Sol Gel Technologies Ltd (SLGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SLGL Q2'26 Earnings: revenue estimate is 75.00K USD - TradingView
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunit - Benzinga
Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd - GuruFocus
HC Wainwright Issues Positive Estimate for SLGL Earnings - MarketBeat
SLGL Reiterated by HC Wainwright & Co. -- Rating Remains Buy - GuruFocus
H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy on Sol Gel stock, $110 target - Investing.com
HC Wainwright Reiterates "Buy" Rating for Sol-Gel Technologies (NASDAQ:SLGL) - MarketBeat
Opaleye Management Inc. Acquires Additional Shares in Sol-Gel Technologies Ltd - GuruFocus
Sol-Gel Technologies (SLGL) Gains Ground: Testing Key Resistance ZonePut Support - dars.gov.et
Sol-Gel Technologies (NASDAQ: SLGL) holder adds 1,695 shares - Stock Titan
Opaleye Management (SLGL) adds Sol-Gel stake with open-market share purchases - Stock Titan
SLGL Q1 2026 Earnings: Narrower Net Loss Beats Street Estimates Despite No RevenueDiluted EPS Report - dars.gov.et
SLGL Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock MovementGuidance Upgrade Report - dars.gov.et
SLGL Technical Analysis & Stock Price Forecast - Intellectia AI
Opaleye boosts Sol-Gel (SLGL) stake with 1,712-share open-market buy - Stock Titan
TKNO Stock Price and Chart — NASDAQ:TKNO - TradingView
Sol-Gel Technologies Ltd. Actuals & Estimates (NASDAQ:SLGL) - TradingView
SLGL Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Price to sales forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Enterprise value to revenue forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
This Nucor Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Sahm
Sol-Gel Technologies (SLGL) Edges Higher, Consolidates Above Key SupportSafe Entry Stocks - dars.gov.et
SLGL Initiates Coverage On Mizuho -- Rating Set to Outperform - GuruFocus
Mizuho Securities Initiates Coverage on Sol-Gel With Outperform Rating, $285 Price Target - Moomoo
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Mizuho initiates Sol Gel stock with Outperform on BCC therapy potential - Investing.com South Africa
Sol-Gel Technologies Initiated at Outperform by Mizuho - Moomoo
ETFs Investing in Sol-Gel Technologies Ltd. Stocks - TradingView
Certain Ordinary Shares of Sol-Gel Technologies Ltd. are subject to a Lock-Up Agreement Ending on 22-JUN-2026. - marketscreener.com
Sol-Gel Technologies (SLGL) Surges 3.4% as Shares Test Key Resistance ZoneHigh Conviction Picks - DonanımHaber
Sol Gel Technologies Ltd (SLGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sol Gel Technologies Ltd (SLGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sol Gel Technologies Ltd (SLGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sol Gel Technologies Ltd (SLGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sol Gel Technologies Ltd Stock (SLGL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jul 14 '26 |
Buy |
73.43 |
920 |
67,556 |
493,936 |
| Opaleye Management Inc. | 10% Owner |
Jul 13 '26 |
Buy |
73.89 |
775 |
57,263 |
493,016 |
| Opaleye Management Inc. | 10% Owner |
Jul 08 '26 |
Buy |
73.69 |
300 |
22,107 |
492,012 |
| Opaleye Management Inc. | 10% Owner |
Jul 10 '26 |
Buy |
73.95 |
229 |
16,935 |
492,241 |
| Opaleye Management Inc. | 10% Owner |
Jul 02 '26 |
Buy |
71.97 |
1,400 |
100,759 |
491,712 |
| Opaleye Management Inc. | 10% Owner |
Jul 01 '26 |
Buy |
71.99 |
312 |
22,461 |
490,312 |
| Opaleye Management Inc. | 10% Owner |
May 20 '26 |
Buy |
64.43 |
1,563 |
100,712 |
490,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '26 |
Buy |
66.87 |
1,937 |
129,527 |
488,437 |
| Opaleye Management Inc. | 10% Owner |
May 12 '26 |
Buy |
67.98 |
1,500 |
101,975 |
486,500 |
| Opaleye Management Inc. | 10% Owner |
Mar 24 '26 |
Buy |
72.00 |
39,665 |
2,855,880 |
485,000 |
2.24%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):